Associations of DMT Therapies with COVID-19 Severity in Multiple Sclerosis: An International Cohort Study
Steve Simpson-Yap,Edward De Brouwer,Tomas Kalincik,Nick Rijke,Jan Hillert,Clare Walton,Gilles Edan,Yves Moreau,Tim Spelman,Lotte Geys,Tina Parciak,Clément Gautrais,Nikola Lazovski,Ashkan Pirmani,Amin Ardeshirdavani,Lars Forsberg,Anna Glaser,Robert McBurney,Hollie Schmidt,Arnfin Bergmann,Stefan Braune,Alexander Stahmann,Rodden Middleton,Amber Salter,Robert J. Fox,Anneke Van Der Welt,Helmut Butzkueven,Juan I. Rojas,Ingrid van der Mei,Nupur Nag,Rumen Ivanov,Guilherme Sciascia do Olival, Alice Estevo Dias,Melinda Magyari,Doralina Guimarães Brum,Maria Fernanda Mendes, Ricardo Alonso,Richard Nicholas,Johana Bauer,Anibal Chertcoff,Ana Zabalza,Georgina Arrambide,Alexander Fidao,Giancarlo Comi,Liesbet M. Peeters SSRN Electronic Journal(2020)
Key words
dmt therapies,multiple sclerosis
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper